P. Guigal

发表

Adjuvant immunotherapy of feline injection-site sarcomas with the recombinant canarypox virus expressing feline interleukine-2 evaluated in a controlled monocentric clinical trial when used in association with surgery and brachytherapy

P. Devauchelle, D. Jas, C. Soyer, 2015 .

From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library.

J. Ward, P. Guigal, S. Kamhawi, 2006, Vaccine.

Ehrlichia canis in Rhipicephalus sanguineus ticks in the Ivory Coast.

D. Raoult, P. Guigal, P. Parola, 2012, Ticks and tick-borne diseases.

Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.

P. Guigal, J. Mumford, L. Fischer, 2006, Veterinary immunology and immunopathology.

Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom

J. Daly, P. Guigal, J. Audonnet, 2005, Veterinary Record.

Protection of puppies against canine herpesvirus by vaccination of the dams

P. Guigal, H. Poulet, V. Leroy, 2001, Veterinary Record.

Three-year duration of immunity in cats vaccinated with a canarypox-vectored recombinant rabies virus vaccine.

D. Jas, P. Guigal, H. Poulet, 2012, Vaccine.

Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.

D. Jas, D. Vernes, P. Guigal, 2015, Veterinary microbiology.

Comparison of antibody responses after vaccination with two inactivated rabies vaccines.

P. Guigal, L. Vergne, F. Cliquet, 2009, Veterinary microbiology.

Compatibility between a rabies vaccine and a combined vaccine against canine distemper, adenovirosis, parvovirosis, parainfluenza virus and leptospirosis.

F. Oberli, P. Guigal, C. Cariou, 2018, Veterinary immunology and immunopathology.

omparison of antibody responses after vaccination with two inactivated abies vaccines

P. Guigal, L. Vergne, F. Cliquet, 2008 .

Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine

P. Guigal, A. Guiot, R. Bey, 2009, Veterinary Microbiology.

Efficacy of a multivalent DAPPi-Lmulti canine vaccine against mortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira experimental challenges

F. Oberli, P. Guigal, C. Cariou, 2016 .

A canine vaccine against Leptospira serovars Icterohaemorrhagiae, Canicola and Grippotyphosa provides cross protection against Leptospira serovar Copenhageni.

F. Oberli, P. Guigal, L. Lemaitre, 2019, Veterinary immunology and immunopathology.

Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.

P. Guigal, D. Jessett, M. Bublot, 2007, American journal of veterinary research.

Evaluation of safety and immunogenicity of feline vaccines with reduced volume.

D. Jas, F. Oberli, P. Guigal, 2021, Vaccine.